1[1]Yang L,Parkin DM,Li LD,et al.Estimation and projection of the national profile of cancer mortality in China: 1991-2005.Br J Cancer.2004,90:2157-2166. 被引量：1
2[2]Turek LP,Smith EM.The genetic progran of genital human papillomaviruse in infection and cancer.Obstet Gynecol Clin North Am,1996,23: 735-758. 被引量：1
3[3]Kuhn L,Denny L,Pollack A,et al.Human papillomavirus DNA testing for cervical cancer screening in low-resouree settings.Natl Cancer Inst,2000,92:818-822. 被引量：1
4[5]Bekkers RL,Massuger LF,Bulten J,et al.Epidemiological and clinical aspects of human papillomavirus detection in the prevention of cervical cancer.Rev Med Virol,2004.14:95-105. 被引量：1
5[6]Jacobs MV,Walboomers JM,Snijders PJ,et al.Distribution of 37 mucosotropic HPV types in women with cytologycally normal cervical smear:The age-related patterns for high-risk and low-risk Types.Int J Cancer,2000,87:221-227. 被引量：1
6[7]Kjaer SK,wan den Brule AJC,Bock JE,et al.Human papillolmavirus: the most significant risk determinant of cervical intraepithelial neoplasia.Int J Cancer,1996,65: 601-660. 被引量：1
7[8]Kjaer SK.Type specific persistence of high risk human papillomavirus(HPV)as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study.BMJ,2002,325:572-578. 被引量：1
8[9]Green S,Walter P,Kumar V,et al.Human oestrogen receptor cDNA:sequence,expression and homology to v-erb-A.Nature,1986,320(6058):134-139. 被引量：1
9[10]Nobbenhuis MA,Walboomers JM,Helmerhorst TJ,et al.Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study.Lancet,1999;354:20-25 被引量：1
10[11]Diaz-Arrastia C,Arany I,Robazetti SC,et al.Clinical and molecular responses in high-grade intraepithelial neoplasia treated with toplical imiquimod 5%.Clin Cancer Res,2001,7:3031-3033 被引量：1
3Massad LS, Einstein MH, Huh WK, et al. 2012 Up dated consen- sus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors[ J]. Obste Gynecol, 2013, 121 (4) :829-846. 被引量：1
4Kjaer SK, van den Brule AJ, Paull G, et al. Type specific persist- ence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study [ J ]. BMJ, 2002,325 (7364) :572-576. 被引量：1
6Hogarth S,Hopkins MM,Rodriguez V.A molecular mouopoly HPV testing,the Pap smear ang the molecularisation of cervical cancer screening in the USA[J].Social Health Nut,2012,34(2):234. 被引量：1
7ACOG Practice Bulletin.Clinical management guidelines for obstetrician-gynecologists,number 61,April 2005.Human papillomavirus[J].Obstet Gynecol,2005(105):905-918. 被引量：1
8Einstein MH,martens MG,Garavcia FA,et al.Clinical Validation of the Gervista HPV HR and 16/18 genotyping tests for use in women with Asc-us cytology[J].Gynecol Oncol,2010,118(2):116-122. 被引量：1
9Wheeler CM, Hunt WC, Joste NE, et al. Human Papillomavirus Genotype Disttibutions : Implications for Vaccination and Cancer Screening in the Unitied States [ J ]. J Natl Cancer Inst,2009,101 (7) :475-487. 被引量：1
